Chief, Molecular Immunoengineering Section
Stadtman Investigator
Education:
D.V.M., 2002, Nihon University
Ph.D., 2006, Nihon University
Biography
Dr. Masaru Kanekiyo obtained his D.V.M. in 2002 and Ph.D. in 2006. Dr. Kanekiyo did his postdoctoral training at the Vaccine Research Center (VRC) with Dr. Gary Nabel studying protein engineering and nanoparticle-based vaccine design. In 2014, Dr. Kanekiyo joined the laboratory of Dr. Barney Graham at the VRC as a Staff Scientist and was later appointed head of the Molecular Immunoengineering Unit. In 2022, Dr. Kanekiyo was named Chief of the Molecular Immunoengineering Section (MIS) at the VRC. Dr. Kanekiyo is also an Earl Stadtman Tenure-Track Investigator. Dr. Kanekiyo focuses his efforts on understanding the vaccine-host interface to define immunological principles that inform the design of effective vaccines against highly challenging targets, such as influenza virus. His interests include vaccine design, protein engineering, self-assembling nanoparticles, immunofocusing and immunotargeting, vaccine-elicited and infection-induced immunity, antibody discovery, animal models, and virus-host co-evolution.